'It’s a small shot in the arm, but it could mean big money for pharmaceutical companies around the world. With flu season upon us and swine flu threatening to reach pandemic proportions, Big Pharma is scrambling to join the vaccine game.
'While the multitudes of flu strains that have popped up in recent years have added to the pharmaceutical industry’s interest in the field, it's the ever-present demand and the idea of prevention that has the sector abuzz.
' "As more diseases become amenable to fixing or prevention through vaccine, the market expands," says Les Funtleyder, Miller Tabak analyst and author of Healthcare Investing: Profiting from the New World of Pharma, Biotech and Health-Care Services. He adds that the industry is finding new diseases all the time that can be vaccinated against, such as HPV or meningitis.'
Editor's Note: Here's the key to effortless, eternal profits for Big Pharma and concomitantly the key to steadily, declining public health:
"Once a vaccine is put on the recommended list for people to get, it will always provide a certain amount of demand," says Funtleyder.
Read more...
Related Post:
Widget by [ Iptek-4u ]
